{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:46Z","timestamp":1707524626975},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,5]]},"DOI":"10.7759\/cureus.26580","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T18:06:47Z","timestamp":1657044407000},"source":"Crossref","is-referenced-by-count":0,"title":["Diabetic Ketoacidosis and COVID-19: A Case Series From an Inner-City Community Teaching Hospital in New York"],"prefix":"10.7759","author":[{"given":"Sowmya","family":"Boddhula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish Kumar","family":"Boddhula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavani","family":"Reddy Garlapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meet J","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunday","family":"Ekanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreedhar","family":"Adapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Fong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha","family":"Balaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swetha","family":"Murthi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Gayam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"WHO Coronavirus (COVID-19) Dashboard. Accessed. July 4, 2022: https:\/\/covid19.who.int\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2020.05.001","article-title":"COVID-19 in diabetic patients: related risks and specifics of management","volume":"81","author":"Orioli L","year":"2020","unstructured":"Orioli L, Hermans MP, Thissen JP, Maiter D, Vandeleene B, Yombi JC. COVID-19 in diabetic patients: related risks and specifics of management. Ann Endocrinol (Paris). 2020, 81:101-9. 10.1016\/j.ando.2020.05.001","journal-title":"Ann Endocrinol (Paris)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang J","year":"2020","unstructured":"Yang J, Zheng Y, Gou X, et al.. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020, 94:91-5. 10.1016\/j.ijid.2020.03.017","journal-title":"Int J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108291","article-title":"High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care","volume":"166","author":"Goldman N","year":"2020","unstructured":"Goldman N, Fink D, Cai J, Lee YN, Davies Z. High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care. Diabetes Res Clin Pract. 2020, 166:108291. 10.1016\/j.diabres.2020.108291","journal-title":"Diabetes Res Clin Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/EC-20-0567","article-title":"Effect of COVID-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes","volume":"10","author":"Kempegowda P","year":"2021","unstructured":"Kempegowda P, Melson E, Johnson A, et al.. Effect of COVID-19 on the clinical course of diabetic ketoacidosis (DKA) in people with type 1 and type 2 diabetes. Endocr Connect. 2021, 10:371-7. 10.1530\/EC-20-0567","journal-title":"Endocr Connect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2020.10.015","article-title":"Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19","volume":"14","author":"Kuchay MS","year":"2020","unstructured":"Kuchay MS, Reddy PK, Gagneja S, Mathew A, Mishra SK. Short term follow-up of patients presenting with acute onset diabetes and diabetic ketoacidosis during an episode of COVID-19. Diabetes Metab Syndr. 2020, 14:2039-41. 10.1016\/j.dsx.2020.10.015","journal-title":"Diabetes Metab Syndr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16376","article-title":"Clinical and epidemiological characteristics of diabetic ketoacidosis in older adults","volume":"68","author":"Schwarzfuchs D","year":"2020","unstructured":"Schwarzfuchs D, Rabaev E, Sagy I, et al.. Clinical and epidemiological characteristics of diabetic ketoacidosis in older adults. J Am Geriatr Soc. 2020, 68:1256-61. 10.1111\/jgs.16376","journal-title":"J Am Geriatr Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-5-200603070-00011","article-title":"Narrative review: ketosis-prone type 2 diabetes mellitus","volume":"144","author":"Umpierrez GE","year":"2006","unstructured":"Umpierrez GE, Smiley D, Kitabchi AE. Narrative review: ketosis-prone type 2 diabetes mellitus. Ann Intern Med. 2006, 144:350-7. 10.7326\/0003-4819-144-5-200603070-00011","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.6.741","article-title":"GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes","volume":"43","author":"Banerji MA","year":"1994","unstructured":"Banerji MA, Chaiken RL, Huey H, et al.. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes. 1994, 43:741-5. 10.2337\/diab.43.6.741","journal-title":"Diabetes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14057","article-title":"COVID-19 infection may cause ketosis and ketoacidosis","volume":"22","author":"Li J","year":"2020","unstructured":"Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020, 22:1935-41. 10.1111\/dom.14057","journal-title":"Diabetes Obes Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang JK","year":"2010","unstructured":"Yang JK, Lin SS, Ji XJ, Guo LM. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010, 47:193-9. 10.1007\/s00592-009-0109-4","journal-title":"Acta Diabetol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20209610","article-title":"The protein expression profile of ACE2 in human tissues","volume":"16","author":"Hikmet F","year":"2020","unstructured":"Hikmet F, M\u00e9ar L, Edvinsson \u00c5, Micke P, Uhl\u00e9n M, Lindskog C. The protein expression profile of ACE2 in human tissues. Mol Syst Biol. 2020, 16:e9610. 10.15252\/msb.20209610","journal-title":"Mol Syst Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.596898","article-title":"SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic \u03b2-cells and in the human pancreas microvasculature","volume":"11","author":"Fignani D","year":"2020","unstructured":"Fignani D, Licata G, Brusco N, et al.. SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic \u03b2-cells and in the human pancreas microvasculature. Front Endocrinol (Lausanne). 2020, 11:596898. 10.3389\/fendo.2020.596898","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.11.005","article-title":"Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19","volume":"32","author":"Kusmartseva I","year":"2020","unstructured":"Kusmartseva I, Wu W, Syed F, et al.. Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19. Cell Metab. 2020, 32:1041-1051.e6. 10.1016\/j.cmet.2020.11.005","journal-title":"Cell Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.11.006","article-title":"SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in \u03b2 cells","volume":"32","author":"Coate KC","year":"2020","unstructured":"Coate KC, Cha J, Shrestha S, et al.. SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in \u03b2 cells. Cell Metab. 2020, 32:1028-1040.e4. 10.1016\/j.cmet.2020.11.006","journal-title":"Cell Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids","volume":"27","author":"Yang L","year":"2020","unstructured":"Yang L, Han Y, Nilsson-Payant BE, et al.. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids. Cell Stem Cell. 2020, 27:125-136.e7. 10.1016\/j.stem.2020.06.015","journal-title":"Cell Stem Cell"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/25347.9760","article-title":"The study of different clinical pattern of diabetic ketoacidosis and common precipitating events and independent mortality factors","volume":"11","author":"Mahesh MG","year":"2017","unstructured":"Mahesh MG, Shivaswamy RP, Chandra BS, Syed S. The study of different clinical pattern of diabetic ketoacidosis and common precipitating events and independent mortality factors. J Clin Diagn Res. 2017, 11:OC42-6. 10.7860\/JCDR\/2017\/25347.9760","journal-title":"J Clin Diagn Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.ej11-0024","article-title":"Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM)","volume":"58","author":"Karavanaki K","year":"2011","unstructured":"Karavanaki K, Karanika E, Georga S, et al.. Cytokine response to diabetic ketoacidosis (DKA) in children with type 1 diabetes (T1DM). Endocr J. 2011, 58:1045-53. 10.1507\/endocrj.ej11-0024","journal-title":"Endocr J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s1521-6616(03)00144-x","article-title":"Cytokine response to diabetic ketoacidosis and its treatment","volume":"108","author":"Hoffman WH","year":"2003","unstructured":"Hoffman WH, Burek CL, Waller JL, Fisher LE, Khichi M, Mellick LB. Cytokine response to diabetic ketoacidosis and its treatment. Clin Immunol. 2003, 108:175-81. 10.1016\/s1521-6616(03)00144-x","journal-title":"Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","author":"Guo W","year":"2020","unstructured":"Guo W, Li M, Dong Y, et al.. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020, e3319. 10.1002\/dmrr.3319","journal-title":"Diabetes Metab Res Rev"},{"key":"ref21","article-title":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Emami A","year":"2020","unstructured":"Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020, 8:e35.","journal-title":"Arch Acad Emerg Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li X","year":"2020","unstructured":"Li X, Xu S, Yu M, et al.. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020, 146:110-8. 10.1016\/j.jaci.2020.04.006","journal-title":"J Allergy Clin Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli CM","year":"2020","unstructured":"Petrilli CM, Jones SA, Yang J, et al.. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020, 369:m1966. 10.1136\/bmj.m1966","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson EJ","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, et al.. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020, 584:430-6. 10.1038\/s41586-020-2521-4","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman N","year":"2020","unstructured":"Holman N, Knighton P, Kar P, et al.. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020, 8:823-33. 10.1016\/S2213-8587(20)30271-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26608","article-title":"Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19","volume":"93","author":"Yang P","year":"2021","unstructured":"Yang P, Wang N, Wang J, Luo A, Gao F, Tu Y. Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19. J Med Virol. 2021, 93:2168-76. 10.1002\/jmv.26608","journal-title":"J Med Virol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.05.008","article-title":"Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and other recent reports","volume":"46","author":"Scheen AJ","year":"2020","unstructured":"Scheen AJ, Marre M, Thivolet C. Prognostic factors in patients with diabetes hospitalized for COVID-19: findings from the CORONADO study and other recent reports. Diabetes Metab. 2020, 46:265-71. 10.1016\/j.diabet.2020.05.008","journal-title":"Diabetes Metab"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108279","article-title":"Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: a retrospective, hospital-based observational case series","volume":"166","author":"Chan KH","year":"2020","unstructured":"Chan KH, Thimmareddygari D, Ramahi A, Atallah L, Baranetsky NG, Slim J. Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: a retrospective, hospital-based observational case series. Diabetes Res Clin Pract. 2020, 166:108279. 10.1016\/j.diabres.2020.108279","journal-title":"Diabetes Res Clin Pract"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically ill patients in the Seattle region - case series","volume":"382","author":"Bhatraju PK","year":"2020","unstructured":"Bhatraju PK, Ghassemieh BJ, Nichols M, et al.. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020, 382:2012-22. 10.1056\/NEJMoa2004500","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108263","article-title":"Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: a retrospective single centre study","volume":"165","author":"Alkundi A","year":"2020","unstructured":"Alkundi A, Mahmoud I, Musa A, Naveed S, Alshawwaf M. Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: a retrospective single centre study. Diabetes Res Clin Pract. 2020, 165:108263. 10.1016\/j.diabres.2020.108263","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100188-diabetic-ketoacidosis-and-covid-19-a-case-series-from-an-inner-city-community-teaching-hospital-in-new-york","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:10Z","timestamp":1707507550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100188-diabetic-ketoacidosis-and-covid-19-a-case-series-from-an-inner-city-community-teaching-hospital-in-new-york"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.26580","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,5]]}}}